Drug Type ASO |
Synonyms FAN1 nuclease inhibitor Therapy(Harness Therapeutics), Huntington’s Disease (Harness Therapeutics) |
Target |
Action inhibitors |
Mechanism FAN1 inhibitors(FANCD2 and FANCI associated nuclease 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Preclinical | United Kingdom | 28 Sep 2024 |